News Preview
Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside
PL Capital predicts further gains in Sai Lifesciences shares, citing increasing pharmaceutical outsourcing, a robust pipeline, and capacity expansion.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.